MedPath

Coagulopathy during surgery for the repair of Extent 4 Thoraco-Abdominal Aortic Aneurysms - feasibility study of the use of Fibrinogen Concentrate by infusion in place of Fresh Frozen Plasma. - Fibrinogen as an alternative to FFP in aortic surgery.

Phase 1
Conditions
Coagulation disturbance during thoracoabdominal aneurysm repair.
Registration Number
EUCTR2009-016709-41-GB
Lead Sponsor
HS Lothian
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

1. Undergoing elective extent 4 thoracoabdominal aneurysm repair.
2. Over 18 years of age.
3. Able to give written informed consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. Re-do surgery.
2. Surgery for ruptured aneurysm.
3. Pregnancy.
4. Females of child-bearing age (less than 45 years) not using medically approved method of contraception.
5. Congenital coagulopathy.
6. Known allergy to study drug.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath